Platinum-containing compound platinum pyrithione suppresses ovarian tumor proliferation through proteasome inhibition-Reference-Cited by-同舟云学术

Platinum-containing compound platinum pyrithione suppresses ovarian tumor proliferation through proteasome inhibition

Published:2017-06-15 Issue:1 Volume:36 Page:
ISSN:1756-9966
Container-title:Journal of Experimental & Clinical Cancer Research
language:en
Short-container-title:J Exp Clin Cancer Res

Author:

Huang Hongbiao,Liu Ni,Liao Yuning,Liu Ningning,Cai Jianyu,Xia Xiaohong,Guo Zhiqiang,Li Yanling,Wen Qirong,Yin Qi,Liu Yan,Wu Qingxia,Rajakumar Dhivya,Sheng Xiujie,Liu Jinbao

Funder

National Natural Science Foundation of China

National Funds for Developing Local Colleges and Universities

General Project from Guangzhou Education Commission

the Science and Technology Program of Guangzhou

the Science and Technology Planning Project of Guangdong Province, China

a Research Award Fund for Outstanding Young Teachers in Guangdong Provincial Higher Education Institutions

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s13046-017-0547-8.pdf

Reference41 articles.

1. Huang W, Zhou Q, Yuan X, Ge ZM, Ran FX, Yang HY, Qiang GL, Li RT, Cui JR. Proteasome Inhibitor YSY01A Enhances Cisplatin Cytotoxicity in Cisplatin-Resistant Human Ovarian Cancer Cells. J Cancer. 2016;7:1133–41.

2. Worzfeld T, Pogge von Strandmann E, Huber M, Adhikary T, Wagner U, Reinartz S, Muller R. The Unique Molecular and Cellular Microenvironment of Ovarian Cancer. Front Oncol. 2017;7:24.

3. Ferrari F, Bellone S, Black J, Schwab CL, Lopez S, Cocco E, Bonazzoli E, Predolini F, Menderes G, Litkouhi B, et al. Solitomab, an EpCAM/CD3 bispecific antibody construct (BiTE(R)), is highly active against primary uterine and ovarian carcinosarcoma cell lines in vitro. J Exp Clin Cancer Res. 2015;34:123.

4. de Melo AC, Paulino E, Garces AH. A Review of mTOR Pathway Inhibitors in Gynecologic Cancer. Oxid Med Cell Longev. 2017;2017:4809751.

5. Bruning A, Burger P, Vogel M, Rahmeh M, Friese K, Lenhard M, Burges A. Bortezomib treatment of ovarian cancer cells mediates endoplasmic reticulum stress, cell cycle arrest, and apoptosis. Invest New Drugs. 2009;27:543–51.

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mapping and visualization of global research progress on deubiquitinases in ovarian cancer: a bibliometric analysis;Frontiers in Pharmacology;2024-09-12

2. Metal Complexes of Omadine (N-Hydroxypyridine-2-thione): Differences of Antioxidant and Pro-Oxidant Behavior in Light and Dark Conditions with Possible Toxicity Implications;Molecules;2023-05-20

3. Deferiprone and Iron–Maltol: Forty Years since Their Discovery and Insights into Their Drug Design, Development, Clinical Use and Future Prospects;International Journal of Molecular Sciences;2023-03-04

4. Gold Nanoparticles Induced Size Dependent Cytotoxicity on Human Alveolar Adenocarcinoma Cells by Inhibiting the Ubiquitin Proteasome System;Pharmaceutics;2023-01-28

5. New Iron Metabolic Pathways and Chelation Targeting Strategies Affecting the Treatment of All Types and Stages of Cancer;International Journal of Molecular Sciences;2022-11-13